Search 

A joint venture with AstraZeneca, focusing on introducing life science companies into Wuxi and develop the biopharmaceutical industry in the city.

Wuxi Xinwu District

Xuanzhu Biopharmaceutical was founded in 2002. In 2012, it became a wholly-owned subsidiary of Sihuan Pharmaceutical. In 2018, Xuanzhu Biopharmaceutical spun-off and became independent, with a registered capital of RMB1.15 billion. Different from other emerging unprofitable biotechnology companies, Xuanzhu Biopharmaceutical is one of the few domestic innovative drug companies with a complete research and development industry chain. It has not only more than a dozen innovative R&D products, but also support from a leading domestic pharmaceutical company in Sihuan Pharmaceutical. With strong production and commercialization capabilities, Xuanzhu Biopharmaceutical possesses the potential of becoming an international enterprise integrating R&D, manufactuing and marketing platforms.

研发、生产、销售

na

Yngzijiang Pharmaceutial Group is an integrated healthcare company in china, our business scope ranges from Pharma(small molcules，biological and TCM), Medical Device and consumer health products. With nearly 20000 employees around the world. We are the biggest private Pharmaceutial company by revenue in China, with a strong revenue growth rate in the past decade. We are open to any coopearation opportunities globally. Welcome to talk to us.

license in innovative medicine and 505(b)(2),R&D generic drugs

focus on CVD, oncology，immunology

healthcare VC

Yonghua Capital is an institutional investor, with headquarter in Shanghai and portfolio overseas. We have invested in over 40 companies in healthcare field over past 5 years.